We are live on
!
Find out more
LA
Lifeworks Advisors Portfolio holdings
AUM
$779M
1-Year Est. Return
21.25%
This Fund
S&P 500
This Quarter
Est. Return
-3.22%
1 Year Est. Return
+21.25%
3 Year Est. Return
+53.77%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$257M
AUM Growth
+$22.2M
(+9.5%)
Cap. Flow
-$10.9M
Cap. Flow
% of AUM
-4.26%
Top 10 Holdings %
Top 10 Hldgs %
24.16%
Holding
193
New
37
Increased
80
Reduced
60
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$2.92M |
| 2 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$2.41M |
| 3 |
Amazon
AMZN
|
+$2.27M |
| 4 |
Moderna
MRNA
|
+$1.88M |
| 5 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.66M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$1.76M |
| 2 |
Micron Technology
MU
|
+$1.09M |
| 3 |
Celanese
CE
|
+$1.09M |
| 4 |
Eli Lilly
LLY
|
+$962K |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$860K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.59% |
| 2 | Technology | 17.28% |
| 3 | Industrials | 7.02% |
| 4 | Consumer Staples | 5.64% |
| 5 | Consumer Discretionary | 3.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
| $8.09M | 3.15% |
171,078
+14,437
| +9% | +$682K |
|
2
iShares US Treasury Bond ETF
GOVT
$43.7B
| $7.87M | 3.06% |
357,250
+55,369
| +18% | +$1.25M |
|
3
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.4B
| $6.5M | 2.53% |
63,743
+9,879
| +18% | +$1.04M |
|
4
Fidelity MSCI Health Care Index ETF
FHLC
$3.31B
| $6.45M | 2.51% |
106,483
+567
| +0.5% | +$35.6K |
|
5
VanEck Merk Gold Trust
OUNZ
$2.52B
| $6.08M | 2.37% |
340,072
-7,952
| -2% | -$148K |
|
6
Fidelity MSCI Information Technology Index ETF
FTEC
$19.6B
| $6.01M | 2.34% |
48,879
-2,552
| -5% | -$328K |
|
7
Vanguard Total International Bond ETF
BNDX
$82.2B
| $5.59M | 2.17% |
116,807
+15,699
| +16% | +$760K |
|
8
Johnson & Johnson
JNJ
$647B
| $5.18M | 2.01% |
33,240
-2,011
| -6% | -$332K |
|
9
Apple
AAPL
$4.93T
| $5.17M | 2.01% |
30,209
-2,033
| -6% | -$373K |
|
10
iShares MBS ETF
MBB
$39.1B
| $5.16M | 2.01% |
58,055
+8,714
| +18% | +$796K |
|
11
Campbell Soup
CPB
$6.74B
| $4.41M | 1.72% |
107,388
+11,474
| +12% | +$502K |
|
|
12
Eli Lilly
LLY
$1.07T
| $4.37M | 1.7% |
8,135
-1,866
| -19% | -$962K |
|
13
Gilead Sciences
GILD
$163B
| $4.24M | 1.65% |
56,565
+3,464
| +7% | +$266K |
|
14
Amgen
AMGN
$204B
| $4.18M | 1.63% |
15,562
+1,279
| +9% | +$319K |
|
15
Merck
MRK
$325B
| $4.15M | 1.62% |
40,328
+2,200
| +6% | +$237K |
|
16
Otis Worldwide
OTIS
$27.9B
| $3.88M | 1.51% |
48,312
-1,682
| -3% | -$144K |
|
17
Cisco
CSCO
$449B
| $3.84M | 1.49% |
71,355
+1,142
| +2% | +$61.6K |
|
18
Pfizer
PFE
$142B
| $3.82M | 1.48% |
115,039
+15,624
| +16% | +$553K |
|
19
AbbVie
ABBV
$457B
| $3.76M | 1.46% |
25,231
+940
| +4% | +$138K |
|
20
Regeneron Pharmaceuticals
REGN
$70.6B
| $3.72M | 1.45% |
4,516
+243
| +6% | +$191K |
|
|
21
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$39.6B
| $3.71M | 1.44% |
119,610
+74,704
| +166% | +$2.41M |
|
22
Oracle
ORCL
$345B
| $3.61M | 1.4% |
34,089
-5,849
| -15% | -$677K |
|
23
Microsoft
MSFT
$2.92T
| $3.55M | 1.38% |
11,250
-1,717
| -13% | -$567K |
|
24
Biogen
BIIB
$29.8B
| $3.22M | 1.25% |
12,522
+2,605
| +26% | +$697K |
|
25
PACCAR
PCAR
$69.2B
| $3.08M | 1.2% |
36,220
+2,473
| +7% | +$210K |
|
Similar funds
BIA
UBV
SG
RTM
TCMX
QCMNJ
TIS
MO
Lifeworks Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Lifeworks Advisors held 193 positions worth $257M, up 9.5% from $235M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lifeworks Advisors withdrew a net $10.9M in Q3 2023, closing 11 positions and reducing 60 holdings. Its most notable exit was Micron Technology, an estimated $1.09M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.
Against the trend, Lifeworks Advisors opened a new position in Vertex Pharmaceuticals worth $2.91M.
- Lifeworks Advisors's largest Q3 2023 buy was Vertex Pharmaceuticals: 8,363 shares worth $2.91M.
- Lifeworks Advisors added most to State Street SPDR Portfolio Developed World ex-US ETF in Q3 2023, an estimated $2.41M increase.
- Lifeworks Advisors's biggest Q3 2023 reduction was Intel, cutting an estimated $1.76M.
- Lifeworks Advisors fully exited Micron Technology in Q3 2023, selling an estimated $1.09M.
- Lifeworks Advisors's ten largest holdings make up 24% of its $257M portfolio in Q3 2023.
- Lifeworks Advisors opened 37 new positions and closed 11 in Q3 2023.
- Lifeworks Advisors's portfolio value rose 9.5% quarter-over-quarter to $257M.
Based on Lifeworks Advisors's 13F filing for Q3 2023, filed 1 Nov 2023.